Alopecia

March 21st 2025

At week 24, the proportion of Asian patients achieving significant hair regrowth (SALT ≤20) was substantially higher in ritlecitinib treatment groups than in placebo groups.

March 18th 2025

According to a clinical trial and in vitro study, TTFE can promote scalp health and hair growth by 96.88% while reducing inflammation.

February 26th 2025

A two-set Mendelian randomization analysis revealed a genetic correlation between depression and androgenetic alopecia.

February 20th 2025

Patients aged 6 to 12 had little to no adverse events and no pharmacokinetic abnormalities were noted.